Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
46M
-
Shares change
-
+5.87M
-
Total reported value, excl. options
-
$5.41B
-
Value change
-
+$712M
-
Put/Call ratio
-
0.39
-
Number of buys
-
86
-
Number of sells
-
-53
-
Price
-
$117.70
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2019
170 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q1 2019.
Ascendis Pharma A/S - ADR (ASND) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46M shares
of 55.6M outstanding shares and own 82.75% of the company stock.
Largest 10 shareholders include FMR LLC (4.69M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.67M shares), RA CAPITAL MANAGEMENT, LLC (4.13M shares), ORBIMED ADVISORS LLC (3.97M shares), BAKER BROS. ADVISORS LP (3.39M shares), Vivo Capital, LLC (2.05M shares), Avoro Capital Advisors LLC (1.8M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.7M shares), FARALLON CAPITAL MANAGEMENT LLC (1.5M shares), and MILLENNIUM MANAGEMENT LLC (1.38M shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.